To investigate the dynamic changes of circulating tumor cells (CTCs) before and after colorectal cancer surgery, focusing on their correlation with lymph node metastasis and prognosis.
Key Findings:
CTCs are released into the bloodstream during surgical resection, indicating potential for metastasis.
The number and characteristics of CTCs correlate with tumor stage, diagnosis, and prognosis, influencing treatment decisions.
Microfluidic technology allows for effective isolation and analysis of CTCs from blood samples.
Interpretation:
Monitoring CTC levels can provide real-time insights into tumor dynamics and treatment efficacy, potentially guiding therapeutic decisions by identifying patients at risk of recurrence.
Limitations:
Small sample size of 81 patients may limit generalizability and statistical power.
Exclusion of patients with certain conditions may introduce selection bias, affecting the applicability of findings.
Conclusion:
CTC monitoring using microfluidic technology may enhance the understanding of colorectal cancer progression and improve patient management strategies, potentially leading to better outcomes.
Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer treatment during pregnancy.
